Share Search
Visit the Share Search
Glaxosmithkline Accounts Summary
| Date of Accounts | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Standard | IFRS | IFRS | IFRS | IFRS | IFRS |
| Millions | Millions | Millions | Millions | Millions | |
| Income Statement | 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
| Revenue | 30,328.00 | 29,324.00 | 24,696.00 | 34,099.00 | 33,754.00 |
| Operating Profit / Loss | 6,745.00 | 6,433.00 | 4,357.00 | 7,783.00 | 6,961.00 |
| Net Interest | -677.00 | -803.00 | -755.00 | -848.00 | -814.00 |
| Pre Tax Profit | 6,064.00 | 5,628.00 | 3,599.00 | 6,968.00 | 6,221.00 |
| Post Tax Profit | 5,308.00 | 4,921.00 | 3,516.00 | 6,388.00 | 5,268.00 |
| Profit for the Period | 5,308.00 | 15,621.00 | 5,096.00 | 6,388.00 | 5,268.00 |
| Equity Holders of Parent Company | 4,928.00 | 14,956.00 | 4,385.00 | 5,749.00 | 4,645.00 |
| Minority Interests | 380.00 | 665.00 | 711.00 | 639.00 | 623.00 |
| Continuing EPS | |||||
| Earnings per Share (Basic) | 121.60p | 110.80p | 66.32p | 115.50p | 93.90p |
| Earnings per Share (Diluted) | 119.90p | 109.20p | 65.44p | 114.10p | 92.60p |
| Earnings per Share (Adjusted) | 155.10p | 139.70p | 90.56p | 115.90p | 123.90p |
| Continuing and Discontinued EPS | |||||
| Earnings per Share (Basic) | 121.60p | 371.40p | 87.68p | 115.50p | 93.90p |
| Earnings per Share (Diluted) | 119.90p | 366.20p | 86.56p | 114.10p | 92.60p |
| Earnings per Share (Adjusted) | 155.10p | 139.70p | 90.56p | 115.90p | 123.90p |
| Dividend per Share | 30.00p | 27.50p | 42.00p | 42.00p | 42.00p |
| Millions | Millions | Millions | Millions | Millions | |
| Balance Sheet | 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
| Non-Current Assets | |||||
| Intangible Assets | 21,579.00 | 21,364.00 | 40,631.00 | 40,421.00 | 41,517.00 |
| Property, Plant and Equipment | 9,957.00 | 9,620.00 | 10,672.00 | 11,006.00 | 10,348.00 |
| Investments | 1,192.00 | 1,541.00 | 2,214.00 | 3,424.00 | 2,151.00 |
| Investment Properties | n/a | n/a | n/a | n/a | n/a |
| Other Financial Assets | n/a | n/a | 18.00 | n/a | 103.00 |
| Other Non-Current Assets | 7,633.00 | 6,852.00 | 6,894.00 | 5,333.00 | 6,082.00 |
| Total Non-Current Assets | 40,361.00 | 39,377.00 | 60,429.00 | 60,184.00 | 60,201.00 |
| Current Assets | |||||
| Inventories | 5,498.00 | 5,146.00 | 5,783.00 | 5,996.00 | 5,947.00 |
| Trade and Other Receivables | 7,385.00 | 7,053.00 | 7,860.00 | 6,952.00 | 7,464.00 |
| Cash at Bank and in Hand | 2,936.00 | 3,723.00 | 4,274.00 | 6,292.00 | 4,707.00 |
| Current Asset Investments | 2,246.00 | 4,154.00 | 61.00 | n/a | n/a |
| Other Current Assets | 579.00 | 693.00 | 696.00 | 1,007.00 | 1,373.00 |
| Total Current Assets | 18,644.00 | 20,769.00 | 18,674.00 | 20,247.00 | 19,491.00 |
| Other Assets | n/a | n/a | n/a | n/a | n/a |
| Total Assets | 59,005.00 | 60,146.00 | 79,103.00 | 80,431.00 | 79,692.00 |
| Current Liabilities | |||||
| Borrowings | 2,813.00 | 3,952.00 | 3,601.00 | 3,725.00 | 6,918.00 |
| Other Current Liabilities | 18,255.00 | 18,858.00 | 20,069.00 | 18,423.00 | 17,132.00 |
| Total Current Liabilities | 21,068.00 | 22,810.00 | 23,670.00 | 22,148.00 | 24,050.00 |
| Net Current Assets | n/a | n/a | n/a | n/a | n/a |
| Non-Current Liabilities | |||||
| Borrowings | 15,205.00 | 17,035.00 | 20,572.00 | 23,425.00 | 23,590.00 |
| Provisions | 806.00 | 821.00 | 4,186.00 | 4,307.00 | 4,480.00 |
| Other Non-Current Liabilities | 9,131.00 | 9,384.00 | 9,333.00 | 9,743.00 | 9,215.00 |
| Total Non-Current Liabilities | 25,142.00 | 27,240.00 | 34,091.00 | 37,475.00 | 37,285.00 |
| Net Assets | 12,795.00 | 10,096.00 | 21,342.00 | 20,808.00 | 18,357.00 |
| Capital and Reserves | |||||
| Share Capital | 1,348.00 | 1,347.00 | 1,347.00 | 1,346.00 | 1,346.00 |
| Share Premium Account | 3,451.00 | 3,440.00 | 3,301.00 | 3,281.00 | 3,174.00 |
| Other Reserves | 1,309.00 | 1,448.00 | 2,463.00 | 6,755.00 | 2,355.00 |
| Retained Earnings | 7,239.00 | 4,363.00 | 7,944.00 | 3,205.00 | 5,109.00 |
| Shareholders Funds | 13,347.00 | 10,598.00 | 15,055.00 | 14,587.00 | 11,984.00 |
| Minority Interests / Other Equity | -552.00 | -502.00 | 6,287.00 | 6,221.00 | 6,373.00 |
| Total Equity | 12,795.00 | 10,096.00 | 21,342.00 | 20,808.00 | 18,357.00 |
| 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | |
| Operating Margin | 22.24% | 21.94% | 17.64% | 22.82% | 20.62% |
| Return on Capital Employed | 67.14% | 61.02% | 48.00% | 65.99% | 59.48% |
| Dividend Cover | 3.69 | 3.17 | 1.13 | 1.45 | 1.55 |
| Dividend Yield | 2.90 | 3.10 | 4.00 | 4.80 | 3.60 |
| PE Ratio | 9.40 | 10.30 | 22.20 | 14.50 | 17.90 |
| PEG | n/a | n/a | n/a | 0.50 | 2.60 |
| Dividend per Share Growth | n/a% | 4.76% | 81.82% | n/a% | n/a% |
| Net Asset Value per Share | -213.46p | -273.82p | -468.74p | -476.61p | -562.81p |